Collegium Pharmaceutical (COLL) Payables (2016 - 2025)
Historic Payables for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $7.6 million.
- Collegium Pharmaceutical's Payables rose 14338.0% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 14338.0%. This contributed to the annual value of $3.9 million for FY2024, which is 5474.0% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Payables stood at $7.6 million for Q3 2025, which was up 14338.0% from $10.9 million recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Payables ranged from a high of $17.9 million in Q1 2025 and a low of $2.4 million during Q2 2024
- Over the past 5 years, Collegium Pharmaceutical's median Payables value was $6.0 million (recorded in 2024), while the average stood at $6.3 million.
- Its Payables has fluctuated over the past 5 years, first plummeted by 6348.27% in 2023, then skyrocketed by 35149.25% in 2025.
- Quarter analysis of 5 years shows Collegium Pharmaceutical's Payables stood at $4.2 million in 2021, then fell by 16.59% to $3.5 million in 2022, then surged by 148.77% to $8.7 million in 2023, then plummeted by 54.74% to $3.9 million in 2024, then soared by 94.38% to $7.6 million in 2025.
- Its Payables was $7.6 million in Q3 2025, compared to $10.9 million in Q2 2025 and $17.9 million in Q1 2025.